Menu

News

You can filter the posts based on tags:

Archives

All posts
2024-04-05

Rapid action against climate change protects against immune-mediated diseases

An international team of researchers, including ILH/DZL scientists Prof Harald Renz and Prof Chrysanthi Skevaki, is investigating how climate change, environmental pollution, and the decline in biodiversity affect our health.
Read more
2024-02-08

One million euros for cutting-edge medical research

The Von Behring-Röntgen Foundation is addressing life-threatening heart and lung diseases, antibiotic resistance, Parkinson's, and coronaviruses through its current research projects. A total of 1 million euros is supporting six innovative initiatives at Philipps University Marburg and Justus Liebig University Giessen, benefiting scientists from ILH and DZL among others, as announced during a ceremony at the foundation's headquarters.
Read more
2024-01-12

How the body repairs lung tissue after viral pneumonia

An international research team, led by lung researchers from Giessen, has discovered a new repair mechanism with therapeutic potential. The work has now been published in "Nature Communications."
Read more
2023-12-04

Young talents honored at the DPLD Young Investigator Meeting

On November 16th and 17th, 2023, the DPLD Young Investigator Meeting took place at the DZL site in Heidelberg. The latest scientific findings in the field of Interstitial Lung Diseases were exchanged, and young investigators were honored.
Read more
2023-11-27

DZL Academy Symposium - Young Scientists Gather in Berlin

"When regeneration goes berserk: challenges and strategies in lung remodeling" was the theme of the DZL Academy Symposium 2023, which brought together 80 young scientists from November 22nd to 24th in Berlin.
Read more
2023-11-14

New insights into potential therapeutic approaches for COPD

Chronic obstructive pulmonary disease (COPD) is considered an incurable condition worldwide and one of the leading causes of death. Researchers from the ILH have now presented groundbreaking findings that offer a promising approach for the therapy of COPD.
Read more
2023-11-03

Autoantibodies discovered as potential biomarkers in idiopathic pulmonary fibrosis

Scientists at the DZL/ILH sites in Munich and Hanover have discovered that newly discovered autoantibodies help to better assess the course of idiopathic pulmonary fibrosis.
Read more
2023-10-10

Macrophages as a therapeutic key for lung cancer

Lung cancer is considered the most frequently lethal tumor disease. ILH scientists have shown that the reprogramming of a specific group of white blood cells, known as tumor-associated macrophages, could be a promising approach for cancer therapy.
Read more
chevron-down